Event Brief
FDA Refuses to Review Moderna’s mRNA Flu Vaccine
Filed: Feb 11, 2026 at 10:00 AM ET
Summary: The FDA has declined to review Moderna's mRNA flu vaccine, impacting its potential rollout.
WHO: FDA, Moderna
WHAT: Refusal to review mRNA flu vaccine
WHEN: Feb 10, 2026 at 8:21 PM ET
WHERE: United States
WHY: Concerns over the vaccine's approval process
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →